1. Clinical Overview
A fixed-dose combination (FDC) therapy designed for the empirical treatment of mixed vaginal infections, primarily targeting bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis. It combines a triazole antifungal (Fluconazole), a macrolide antibiotic (Azithromycin), and a nitroimidazole antiprotozoal/antibacterial (Secnidazole) to provide broad-spectrum coverage against common vaginal pathogens. This FDC is intended as a single-dose or short-course therapy to improve patient compliance. Its use is controversial and subject to regulatory scrutiny in India due to concerns about antibiotic overuse and the promotion of antimicrobial resistance (AMR).
| Onset | Duration | Bioavailability |
|---|---|---|
| Fluconazole: Symptomatic relief in 24-72 hours. Azithromycin: Peak plasma concentrations in 2-3 hours. Secnidazole: Peak plasma concentrations in 1-4 hours. | Fluconazole: Up to 72 hours in plasma, tissue effects longer. Azithromycin: Prolonged tissue half-life, therapeutic concentrations for 5-7 days post-dose. Secnidazole: Plasma half-life ~17-29 hours, providing sustained effect. | Fluconazole: >90% (oral). Azithromycin: ~37% (oral, food reduces absorption). Secnidazole: >90% (oral). |
2. Mechanism of Action
This combination exerts a synergistic or additive effect against a polymicrobial vaginal infection. Fluconazole inhibits fungal ergosterol synthesis, damaging the cell membrane of Candida species. Azithromycin binds to the 50S ribosomal subunit of susceptible bacteria (e.g., Gardnerella vaginalis, Chlamydia trachomatis), inhibiting protein synthesis. Secnidazole undergoes intracellular reduction of its nitro group, generating cytotoxic radicals that damage DNA and disrupt cellular processes of anaerobic bacteria (e.g., BV-associated anaerobes) and protozoa (Trichomonas vaginalis).
3. Indications & Uses
- Empirical treatment of mixed vaginal infections presenting as vaginal discharge syndrome (when confirmed/suspected polymicrobial infection)
- Treatment of concurrent vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV)
- Treatment of concurrent vulvovaginal candidiasis (VVC) and trichomoniasis
4. Dosage & Administration
Adult Dosage: A single oral dose of one sachet/kit containing Fluconazole 150mg + Azithromycin 1g + Secnidazole 1g, taken as directed. Some brands may recommend a two-dose regimen (e.g., one dose on Day 1 and Day 3). MUST be taken under medical supervision.
Administration: Take orally with a full glass of water. Azithromycin absorption is reduced by food; take on an empty stomach (at least 1 hour before or 2 hours after a meal) for optimal absorption. The entire sachet/kit contents should be taken at once. Do not crush or chew the tablets/capsules.
5. Side Effects
Common side effects may include:
- Nausea
- Abdominal pain/cramps
- Diarrhea or loose stools
- Headache
- Dyspepsia
- Altered taste (metallic taste - Secnidazole)
- Vaginal burning/itching (may persist initially)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Warfarin/Acenoocumarol | Fluconazole inhibits metabolism, increasing INR and bleeding risk. | Major |
| Sulfonylureas (e.g., Glimepiride) | Fluconazole increases sulfonylurea levels, causing hypoglycemia. | Major |
| Phenytoin | Fluconazole increases phenytoin levels; phenytoin may decrease fluconazole levels. | Major |
| Cyclosporine, Tacrolimus | Fluconazole increases calcineurin inhibitor levels, risk of nephrotoxicity. | Major |
| Rifampicin | Reduces Fluconazole levels significantly. | Major |
| Drugs prolonging QT interval (e.g., Amiodarone, Sotalol, Fluoroquinolones, Antipsychotics) | Additive risk of QT prolongation and arrhythmias with Azithromycin. | Major |
| Digoxin | Azithromycin may increase digoxin levels (by affecting gut flora). | Moderate |
| Ergot alkaloids (Ergotamine) | Risk of ergotism with Azithromycin (CYP3A4 inhibition). | Major |
| Disulfiram | Concurrent use with Secnidazole can cause psychotic reactions (disulfiram-like reaction). | Major |
| Alcohol | Secnidazole can cause disulfiram-like reaction (flushing, nausea, vomiting, tachycardia). | Major |
| Lithium | Azithromycin may increase lithium levels. | Moderate |
| Colchicine | Azithromycin may increase colchicine levels, risk of toxicity (especially in renal impairment). | Major |
7. Patient Counselling
- DO take the complete dose as prescribed by your doctor, even if symptoms improve.
- DO take Azithromycin on an empty stomach (1 hr before or 2 hrs after food).
- DO inform your doctor about all other medicines you are taking, including OTC and herbal products.
- DO use effective non-hormonal contraception during treatment if applicable.
- DO NOT consume alcohol or products containing alcohol (syrups, tonics) for at least 3-5 days after taking this medicine.
- DO NOT take antacids containing aluminum or magnesium within 2 hours of Azithromycin dose.
- DO NOT share this medication with anyone else.
8. Toxicology & Storage
Overdose: Nausea, vomiting, diarrhea, severe abdominal pain. Neurological symptoms: seizures (Secnidazole), dizziness, confusion. Potential for severe cardiac arrhythmias (QT prolongation from Azithromycin). Liver function abnormalities.
Storage: Store below 30°C, in a cool, dry place. Protect from light and moisture. Keep out of reach of children. Do not use after the expiry date printed on the pack.